INSP Stock Price, Analysis & Fundamentals | Inspire Medical Systems, Inc.

Analysis

Inspire Medical Systems, Inc. is a company in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $2.80 billion and annual revenues exceeding $882 million, Inspire operates on a significant scale. The company has a workforce of approximately 1,246 employees. From a financial health perspective, Inspire demonstrates notable profitability with gross margins reaching 84.9%, operating margins at 4.3%, and profit margins at 5.0%. Return on Equity (ROE) stands at 6.5% and Return on Assets (ROA) is 2.9%. The company's balance sheet shows a manageable debt level of $32.58 million, juxtaposed against cash reserves totaling $322.59 million, resulting in a current ratio of 5.29. Valuation metrics indicate that Inspire has a P/E ratio (TTM) of 63.17 and a forward P/E of 56.56. The company's revenue growth rate over the past year is 10.5%, with earnings growth at -43.6%.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Visit website →

INSP

Price History (1Y)

Analysis

About Inspire Medical Systems, Inc.

Key Statistics

Company Info